Company Filing History:
1 out of 832,812 Years Active: 2020
Title: Innovations in Radiotherapy: The Contributions of Kenneth Hogstrom
Introduction
Kenneth Hogstrom is a notable inventor based in Baton Rouge, Louisiana. He has made significant contributions to the field of radiotherapy, particularly in enhancing the effectiveness of electron beam radiation therapy. His innovative approach addresses the challenges associated with delivering uniform doses to target volumes containing cancer cells.
Latest Patents
Kenneth Hogstrom holds a patent for a "Passive radiotherapy intensity modulator for electrons." This invention aims to improve the uniformity of dose distribution in electron beam radiation therapy. Traditional methods often struggle with non-homogeneous dose distributions due to irregular patient surfaces. Hogstrom's method utilizes spatially-modulated beam intensities to restore target dose homogeneity. By employing Island Blocks or Island Apertures in the beam's path, his approach effectively modulates electron flux while maintaining energy efficiency. This novel method is not only effective but also cost-efficient, making it easy to integrate into existing electron therapy machines.
Career Highlights
Throughout his career, Kenneth Hogstrom has focused on advancing techniques in radiotherapy. His work has been instrumental in developing methods that enhance the precision of cancer treatments. With a patent count of 1 patent, he continues to contribute to the field through innovative solutions.
Collaborations
Kenneth Hogstrom has collaborated with Robert G Carver, working together to push the boundaries of radiotherapy technology. Their partnership has fostered advancements that benefit the medical community and improve patient outcomes.
Conclusion
Kenneth Hogstrom's contributions to radiotherapy exemplify the impact of innovation in medical technology. His patented method for spatially-modulating electron beam intensities represents a significant advancement in cancer treatment. Through his work, he continues to pave the way for more effective and efficient therapies.